AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease
A new study reveals a promising drug reduces vision loss in Stargardt disease, showing significant safety and efficacy over 2 years.
AAO 2025: Ken Beckman discusses trial demonstrating safety and efficacy of epithelium-on CXL
A study shows enhanced safety and efficacy in epi-on cross-linking for keratoconus, utilizing oxygen-rich boost goggles during treatment.
AAO 2025: Prof Peter Stalmans says single-use lenses are better for patients
At the 2025 Academy of American Ophthalmology meeting, Prof Stalmans described safety and efficacy benefits of disposable non-contact vitrectomy lenses
AAO 2025: Subretinal drusenoid deposits in Black and Hispanic patients with AMD
The investigators noted that this report is the first about subretinal drusenoid deposits in Black and Hispanic patients with age-related macular degeneration
AAO debuts technician training platform ahead of 2025 meeting
The video-driven platform will improve workflow, education and engagement, said Inder Paul Singh, MD
Biotech Healthcare launches Optiflex XTENSE Comfort Plus EDOF IOL
The full range of vision lens debuted at the 2025 ESCRS meeting in Copenhagen
Research describes a novel biomarker of tissue hypoxia in PDR and RVO
Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported
What to expect at the American Academy of Ophthalmology meeting
The agenda includes subspecialty days, evening events and partner programmes from practice management organisations
Do cosmetic contact lenses have a lower microbial keratitis rate than keratopigmentation?
Research finding challenge the widely-held notion that cosmetic contact lenses are the safest technique for changing eye colour
Insights into atropine usage
A pair of studies, conducted in Taiwan and China, indicate that red light therapy could serve as an effective and safe alternative to atropine
Broader perspective for the treatment approach on retinal neovascular diseases
Biomarkers and fine-tuned staging are key to progress in improving retinal care, according to Fanka Gilevska, MD, PhD
AAO 2025: What the Eye Care Network's editorial advisory board members are presenting
Complex Glaucoma Management: From Anterior to Posterior Segment
Intravitreal complement inhibitor treatment for GA viewed favorably by patients
Patient response focused on perceived vision-related quality of life outcomes, investigators said
NHS Tayside streamlines UK cataract surgeries with Lutra Health
The procurement follows an 18-month pilot at a high-volume surgery in Dundee, Scotland
Eyenuk deploys autonomous AI eye screening technology throughout Norway
EyeArt uses artificial intelligence for autonomous detection of vision-threatening diabetic retinopathy
MacuMira launches first Health Canada-approved device for AMD treatment
The newly-approved technology delivers low-dose microcurrents through closed eyelids to stimulate retinal cells
EURETINA 2025: Diabetic eye disease needs a new staging system
The current staging system fails to fully capture the neurovascular unit's status, said Stela Vujosevic, Md, PhD, FEBO
European Commission grants marketing authorisation to aflibercept biosimilar EYLUXVI (ALT-L9)
Alteogen received a positive CHMP opinion for EYLUXVI in July 2025
Heidelberg Engineering, STAAR, Ziemer to showcase latest technologies at ESCRS 2025
Leading companies spotlight innovations in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen
BVI, VirtuaLens will showcase new technologies at ESCRS 2025
At the ESCRS meeting, cataract surgeons can get familiar with BVI's Virtuoso platform and VirtuaLens' immersive VR IOL simulator
Upcoming company presentations from Alcon, J&J, B+L at ESCRS 2025
Alcon, Bausch + Lomb and Johnson & Johnson will debut new research findings during the European Society of Cataract and Refractive Surgeons Congress in Copenhagen, Denmark
Ciliatech leadership comments on CE mark for novel glaucoma device
Ahead of the ESCRS congress and iNovation day, we go behind the scenes with Ciliatech founder Philippe Sourdille, MD, and president Olivier Benoit
EURETINA grants Prithvi Ramtohul, MD, 2025 Ramin Tadayoni Award
Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies
The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD).
EURETINA industry previews: Beacon Therapeutics, Nanoscope Therapeutics and Valitor
Presentation topics will include therapies for age-related macular degeneration, X-linked retinitis pigmentosa and other retinal pathologies
Ashvattha Therapeutics, Clearside Biomedical, ZEISS preview EURETINA presentations
Clinical leaders including Susan Schneider, MD; Lejla Vajzovic, MD; and Harvey Uy, MD, will share new clinical findings
Progression rates vary in subtypes of geographic atrophy lesions
An understanding of GA growth kinetics is key to addressing the pathophysiology of age-related macular degeneration
The Eye Care Network's clinical advisors will present at EURETINA
Where to find members of our editorial board at this year's European Society of Retina Specialists Congress
What to expect at this year's European Society of Retina Specialists (EURETINA) Congress
Answering all the questions ophthalmologists may have ahead of the EURETINA Congress in Paris, France